Stuart Kupfer, MD
Chief Medical Officer at Cytokinetics
Nucleras Biosciences•Greater Chicago Area, United States
View LinkedIn ProfileExperience42+ Years
Executive Overview
Innovative physician-scientist with extensive leadership experience in clinical, regulatory, and business development strategy and clinical and basic research; 20 years of experience in pharmaceutical development of novel agents in multiple therapeutic areas, leading to successful NDA, MAA, and PMDA approvals; strong relationships with internal and external stakeholders, including FDA, NIH, and academic advisors.
Career Timeline
- CytokineticsCurrent2020–Present· 6 yrs 9 mos
- Chief Medical OfficerCurrent2020–Present
- Nucleras BiosciencesCurrentJul 2018–Present· 8 yrs 3 mos
- Chief Scientific and Medical Officer; Co-founderCurrentJul 2018–Present
- 2016–Present· 10 yrs 9 mos
- Pharmaceutical ExecutiveCurrent2016–Present
- Nov 2004–2016· 11 yrs 2 mos
- Vice President, Clinical Science, Cardiovascular and Metabolic Diseases2011–2016
- Executive Medical Director2007–2011
- Senior Medical DirectorNov 2004–2007
- May 2003–Nov 2004· 1 yr 6 mos
- Global Medical DirectorMay 2003–Nov 2004
- 1998–Apr 2003· 5 yrs 3 mos
- Director, Medical1998–Apr 2003
- Jul 1994–Dec 1997· 3 yrs 5 mos
- Assistant ProfessorJul 1994–Dec 1997
- Jul 1989–Jun 1994· 4 yrs 11 mos
- Research Assistant ProfessorJul 1992–Jun 1994
- Fellow in Pediatric EndocrinologyJul 1989–Jun 1992
- Jul 1987–Jun 1989· 1 yr 11 mos
- Research FellowJul 1987–Jun 1989
- Jul 1984–Jun 1987· 2 yrs 11 mos
- Resident in PediatricsJul 1984–Jun 1987
Education
Bachelor's degree
Microbiology, General
University of Florida
Doctor of Medicine (MD)
University of Florida College of MedicineExecutive Relationship Map
Reports To
Stuart Kupfer, MD
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
ThrombosisClinical ResearchDiabetesMetabolismCross-functional Team LeadershipEndocrinologyRegulatory Strategy DevelopmentClinical TrialsClinical Development StrategyPhysician-ScientistCardiovascular Outcomes TrialsCardiovascular DiseaseTherapeutic Area LeadershipFDA Advisory MeetingsDyslipidemiaNDA and MAA ApprovalsPharmaceutical IndustryBiotechnologyCardiologyObesity